These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


94 related items for PubMed ID: 22434106

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1.
    Bühlmann N, Leuthäuser K, Muff R, Fischer JA, Born W.
    Endocrinology; 1999 Jun; 140(6):2883-90. PubMed ID: 10342881
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. RAMPs and CGRP receptors.
    Barwell J, Wootten D, Simms J, Hay DL, Poyner DR.
    Adv Exp Med Biol; 2012 Jun; 744():13-24. PubMed ID: 22434104
    [Abstract] [Full Text] [Related]

  • 29. Antiapoptotic effect of calcitonin gene-related peptide on oxidative stress-induced injury in H9c2 cardiomyocytes via the RAMP1/CRLR complex.
    Sueur S, Pesant M, Rochette L, Connat JL.
    J Mol Cell Cardiol; 2005 Dec; 39(6):955-63. PubMed ID: 16242145
    [Abstract] [Full Text] [Related]

  • 30. The effects of C-terminal truncation of receptor activity modifying proteins on the induction of amylin receptor phenotype from human CTb receptors.
    Udawela M, Christopoulos G, Morfis M, Tilakaratne N, Christopoulos A, Sexton PM.
    Regul Pept; 2008 Jan 10; 145(1-3):65-71. PubMed ID: 17884192
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Multiple ramp domains are required for generation of amylin receptor phenotype from the calcitonin receptor gene product.
    Zumpe ET, Tilakaratne N, Fraser NJ, Christopoulos G, Foord SM, Sexton PM.
    Biochem Biophys Res Commun; 2000 Jan 07; 267(1):368-72. PubMed ID: 10623626
    [Abstract] [Full Text] [Related]

  • 37. Alterations of adrenomedullin and its receptor system components in calcified vascular smooth muscle cells.
    Pan CS, Qi YF, Wang SH, Zhao J, Bu DF, Li GZ, Tang CS.
    Regul Pept; 2004 Aug 15; 120(1-3):77-83. PubMed ID: 15177923
    [Abstract] [Full Text] [Related]

  • 38. Role of the N-terminal domain of the calcitonin receptor-like receptor in ligand binding.
    Chauhan M, Rajarathnam K, Yallampalli C.
    Biochemistry; 2005 Jan 18; 44(2):782-9. PubMed ID: 15641806
    [Abstract] [Full Text] [Related]

  • 39. RAMPs as drug targets.
    Sexton PM, Poyner DR, Simms J, Christopoulos A, Hay DL.
    Adv Exp Med Biol; 2012 Jan 18; 744():61-74. PubMed ID: 22434108
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.